HIMS vs. MDT: Hims & Hers Health vs. Medtronic Stock Comparison

Company Profile

Hims & Hers Health (HIMS) and Medtronic (MDT) both fall under the Health Care Equipment & Services industry group, but HIMS is classified in Health Care Providers & Services while MDT is classified in Health Care Equipment & Supplies.

Medtronic (MDT) has more than two decades of public-market history since May 2, 1973, whereas Hims & Hers Health (HIMS) listed on September 13, 2019 and has a much shorter record to draw on.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Hims & Hers Health (HIMS) has a highly aggressive beta of 2.42, indicating much higher sensitivity to broad-market moves, while Medtronic (MDT) is defensive at 0.55 and tends to be less market-sensitive — a wide gap in beta profiles.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Hims & Hers Health (HIMS) reports a negative ROE of -2.66%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Medtronic (MDT) reports 9.84%, ranking against industry peers normally.

Hims & Hers Health (HIMS) reports a negative net margin of -0.56%, usually indicating a net loss over the period. Meanwhile Medtronic (MDT) reports 13.20%, ranking against industry peers normally.

Hims & Hers Health (HIMS) reports a negative operating margin of -7.90%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Medtronic (MDT) reports 22.05%, ranking against industry peers normally.

Profitability Metrics

Growth

Hims & Hers Health (HIMS) at 59.00% clears its industry range for revenue growth, far stronger top-line momentum than Medtronic (MDT) at 8.43%, which is closer to a typical peer reading.

Only one side can be read here: Hims & Hers Health (HIMS) reports EPS growth of -3.77%, ranked against its industry; Medtronic (MDT) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Both Hims & Hers Health (HIMS) at 1.69 and Medtronic (MDT) at 2.13 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

Medtronic (MDT) at 0.58 is near its industry mid-range for debt-to-equity ratio, while Hims & Hers Health (HIMS) at 2.54 sits above its benchmark range, pointing to a heavier debt load relative to equity.

Financial Strength Metrics

Dividends

Hims & Hers Health (HIMS) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Medtronic (MDT) reports a yield of 3.31%, ranking against industry peers normally.

Hims & Hers Health (HIMS) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Medtronic (MDT) reports a payout of 76.14%, ranking against industry peers normally.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: Medtronic (MDT) trades at 23.06 times trailing earnings, ranked against its peers, while Hims & Hers Health (HIMS) has no P/E ratio this period.

On P/S ratio, both Hims & Hers Health (HIMS) at 3.09 and Medtronic (MDT) at 3.07 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

Medtronic (MDT) at 2.26 sits near its industry’s typical P/B ratio, while Hims & Hers Health (HIMS) at 16.33 prices above its benchmark range — HIMS looks rich relative to book.

Valuation Metrics